Table 1.
Clinical data and relative M371 expression in serum of patients with testicular non-germ cell tumours
| Patient ID | Age (years) | Dignity | Histology | RQ M371 |
|---|---|---|---|---|
| 1 | 30 | Benign | Leydig cell tumor | 0.00 |
| 2 | 47 | Benign | Leydig cell tumor | 0.00 |
| 3 | 22 | Benign | Leydig cell tumor | 0.00 |
| 4 | 44 | Benign | Leydig cell tumor | 0.00 |
| 5 | 52 | Benign | Leydig cell tumor | 0.00 |
| 6 | 64 | Benign | Leydig cell tumor | 0.00 |
| 7 | 44 | Benign | Leydig cell tumor | 0.00 |
| 8 | 39 | Benign | Leydig cell tumor | 0.00 |
| 9 | 37 | Benign | Leydig cell tumor | 0.00 |
| 10 | 29 | Benign | Leydig cell tumor | 0.00 |
| 11 | 42 | Benign | Leydig cell tumor | 0.00 |
| 12 | 31 | Benign | Leydig cell tumor | 0.00 |
| 13 | 42 | Benign | Leydig cell tumor | 0.00 |
| 14 | 36 | Benign | Leydig cell tumor | 0.75 |
| 15 | 69 | Benign | Leydig cell tumor | 0.00 |
| 16 | 69 | Benign | Leydig cell tumor | 0.00 |
| 17 | 39 | Benign | Leydig cell tumor | 0.00 |
| 18 | 39 | Benign | Leydig cell tumor | 6.96 |
| 19 | 28 | Benign | Leydig cell tumor | 0.00 |
| 20 | 28 | Benign | Leydig cell tumor | 0.00 |
| 21 | 34 | Benign | Leydig cell tumor | 0.00 |
| 22 | 50 | Benign | Leydig cell tumor | 0.00 |
| 23 | 46 | Benign | Leydig cell tumor | 0.00 |
| 24 | 51 | Benign | Leydig cell tumor | 0.99 |
| 25 | 37 | Benign | Leydig cell tumor | 0.74 |
| 26 | 37 | Benign | Leydig cell tumor | 0.00 |
| 27 | 49 | Benign | Leydig cell tumor | 1.82 |
| 28 | 38 | Benign | Leydig cell tumor | 0.00 |
| 29 | 79 | Benign | Leydig cell tumor | 0.00 |
| 30 | 32 | Benign | Leydig cell tumor | 0.00 |
| 31 | 33 | Benign | Leydig cell tumor | 0.00 |
| 32 | 61 | Benign | Leydig cell tumor | 0.00 |
| 33 | 64 | Benign | Leydig cell tumor | 0.43 |
| 34 | 53 | Benign | Leydig cell tumor | 2.17 |
| 35 | 64 | Benign | Leydig cell tumor | 0.00 |
| 36 | 40 | Benign | Leydig cell tumor | 0.00 |
| 37 | 49 | Benign | Leydig cell tumor | 0.00 |
| 38 | 44 | Benign | Leydig cell tumor | 0.00 |
| 39 | 50 | Benign | Leydig cell tumor | 0.00 |
| 40 | 49 | Benign | Leydig cell tumor | 0.50 |
| 41 | 31 | Benign | Sertoli cell tumor | 0.00 |
| 42 | 40 | Benign | Sertoli cell tumor | 0.00 |
| 43 | 62 | Benign | Sertoli cell tumor | 0.00 |
| 44 | 18 | Benign | Sertoli cell tumor | 0.00 |
| 45 | 47 | Benign | Sertoli cell tumor | 0.00 |
| 46 | 48 | Benign | Sertoli cell tumor | 0.00 |
| 47 | 26 | Benign | Sertoli cell tumor | 0.00 |
| 48 | 29 | Benign | Sertoli cell tumor | 0.00 |
| 49 | 37 | Benign | Sertoli cell tumor | 0.00 |
| 50 | 55 | Benign | Sertoli cell tumor | 0.00 |
| 51 | 37 | Benign | Sertoli cell tumor | 0.00 |
| 52 | 41 | Benign | Sertoli cell tumor | 0.00 |
| 53 | 26 | Benign | Sertoli cell tumor | 0.00 |
| 54 | 43 | Benign | Sertoli cell tumor | 2.35 |
| 55 | 18 | Benign | Sertoli cell tumor | 0.00 |
| 56 | 67 | Benign | Sertoli cell tumor | 0.00 |
| 57 | 51 | Benign | Sertoli cell tumor | 0.00 |
| 58 | 49 | Benign | Sertoli cell tumor | 0.71 |
| 59 | 32 | Benign | Granulosa cell tumor | 0.00 |
| 60 | 22 | Benign | Granulosa cell tumor | 0.00 |
| 61 | 21 | Benign | Unspecified GST | 0.32 |
| 62 | n.a | Benign | Adenomatoid tumor | 0.00 |
| 63 | 29 | Benign | Adenomatoid tumor | 0.00 |
| 64 | 51 | Benign | Adenomatoid tumor | 0.81 |
| 65 | 34 | Benign | Adenomatoid tumor | 0.00 |
| 66 | 34 | Benign | Adenomatoid tumor | 0.00 |
| 67 | 44 | Benign | Adenomatoid tumor | 0.00 |
| 68 | 81 | Benign | Hemangioma | 0.00 |
| 69 | 64 | Benign | Hemangioma | 0.00 |
| 70 | 74 | Malignant | Lymphoma | 0.00 |
| 71 | 66 | Malignant | Lymphoma | 0.00 |
| 72 | 70 | Malignant | Lymphoma | 0.00 |
| 73 | n.a | Malignant | Lymphoma | 0.00 |
| 74 | n.a | Malignant | Lymphoma | 0.00 |
| 75 | 74 | Malignant | Lymphoma | 0.00 |
| 76 | 83 | Malignant | Lymphoma | 0.00 |
| 77 | 89 | Malignant | Lymphoma | 0.00 |
| 78 | 46 | Malignant | Lymphoma | 0.00 |
| 79 | 53 | Malignant | Lymphoma | 0.00 |
| 80 | 69 | Malignant | Lymphoma | 0.00 |
| 81 | 27 | Malignant | Lymphoma | 0.00 |
| 82 | 76 | Malignant | Lymphoma | 0.00 |
| 83 | 62 | Malignant | Lymphoma | 3.03 |
| 84 | 40 | Malignant | Lymphoma | 0.00 |
| 85 | 80 | Malignant | Lymphoma | 8.34 |
| 86 | 76 | Malignant | Lymphoma | 0.00 |
| 87 | 61 | Malignant | Lymphoma | 0.00 |
| 88 | 67 | Malignant | Lymphoma | 0.00 |
| 89 | 61 | Malignant | Lymphoma | 2.23 |
| 90 | 85 | Malignant | Lymphoma | 0.00 |
| 91 | 71 | Malignant | Lymphoma | 2.06 |
| 92 | 68 | Malignant | Lymphoma | 0.00 |
| 93 | 70 | Malignant | Lymphoma | 0.00 |
| 94 | 55 | Malignant | Lymphoma | 25.28 |
| 95 | 52 | Malignant | Lymphoma | 0.00 |
| 96 | 69 | Malignant | Lymphoma | 0.00 |
| 97 | 87 | Malignant | Lymphoma | 4.26 |
| 98 | 77 | Malignant | Lymphoma | 0.00 |
| 99 | 99 | Malignant | Lymphoma | 9.19 |
RQ Relative quantity, GST gonadal stroma tumor, n.a. not available